CHANGHONG TECHNOLOGY(300151)2023-08-31 01:31Group 1: Market Environment and Challenges - The company faces instability in the market due to multiple factors, including post-pandemic effects, a weak medical testing industry, and reduced market demand, leading to challenges in domestic orders [2] - International trade conflicts have also impacted the company's PCB business, with overall domestic market demand experiencing a decline [2] - Despite challenges, overseas factory orders remain stable, prompting the company to invest and expand its overseas production bases [2] Group 2: Business Performance and Future Outlook - The medical business has seen significant development opportunities during the pandemic, gaining recognition from numerous international clients and entering their supply chains [2] - The company plans to collaborate comprehensively with domestic and international clients in areas such as immunology, chemiluminescence, and molecular diagnostics in the second half of the year [3] - The market for medical consumables is substantial, with a single international IVD giant's annual global procurement reaching 8 billion RMB, and the blood glucose monitoring market potentially reaching several billion USD [4] Group 3: Product Development and Revenue Generation - The company is currently validating its wafer carrier products, which include FOUP and FOSB, but has not yet generated revenue from these products [4] - The company is focusing on differentiated product development strategies, starting with the most challenging 12-inch wafer carriers [4] - The mold projects reported are newly added concepts from the last 12 months, and the company will continue to disclose operational updates to keep investors informed [4]